| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.35 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |